|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Magrina JF, Mutone NF, Weaver AL, Magtibay
PM, Fowler RS and Cornella JL: Laparoscopic lymphadenectomy and
vaginal or laparoscopic hysterectomy with bilateral
salpingo-oophorectomy for endometrial cancer: Morbidity and
survival. Am J Obstet Gynecol. 181:376–381. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
National Cancer Institute: Cancer Stat
Facts: Endometrial Cancer. 2015.
|
|
4
|
Klionsky DJ and Emr SD: Autophagy as a
regulated pathway of cellular degradation. Science. 290:1717–1721.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
White E and DiPaola RS: The double-edged
sword of autophagy modulation in cancer. Clin Cancer Res.
15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Du F, Feng Y, Fang J and Yang M:
MicroRNA-143 enhances chemosensitivity of Quercetin through
autophagy inhibition via target GABARAPL1 in gastric cancer cells.
Biomed Pharmacother. 74:169–177. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu YP, Dong FX, Chai X, Zhu S, Zhang BL
and Gao DS: Role of autophagy in capsaicin-induced apoptosis in
U251 Glioma Cells. Cell Mol Neurobiol. 36:737–743. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nazim UM and Park SY: Genistein enhances
TRAIL-induced cancer cell death via inactivation of autophagic
flux. Oncol Rep. 34:2692–2698. 2015.PubMed/NCBI
|
|
9
|
Zhang Y, Jiang F, Bao W, Zhang H, He X,
Wang H and Wan X: SOX17 increases the cisplatin sensitivity of an
endometrial cancer cell line. Cancer Cell Int. 16:292016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu N, Zhang J, Shen C, Luo Y, Xia L, Xue F
and Xia Q: Cisplatin-induced downregulation of miR-199a-5p
increases drug resistance by activating autophagy in HCC cell.
Biochem Biophys Res Commun. 423:826–831. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kang R, Wang ZH, Wang BQ, Zhang CM, Gao W,
Feng Y, Bai T, Zhang HL, Huang-Pu H and Wen SX: Inhibition of
autophagy-potentiated chemosensitivity to cisplatin in laryngeal
cancer Hep-2 cells. Am J Otolaryngol. 33:678–684. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ren JH, He WS, Nong L, Zhu QY, Hu K, Zhang
RG, Huang LL, Zhu F and Wu G: Acquired cisplatin resistance in
human lung adenocarcinoma cells is associated with enhanced
autophagy. Cancer Biother Radiopharm. 25:75–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen J, Zhao KN, Li R, Shao R and Chen C:
Activation of PI3K/Akt/mTOR pathway and dual inhibitors of PI3K and
mTOR in endometrial cancer. Curr Med Chem. 21:3070–3080. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Slomovitz BM and Coleman RL: The
PI3K/AKT/mTOR pathway as a therapeutic target in endometrial
cancer. Clin Cancer Res. 18:5856–5864. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lum JJ, Bauer DE, Kong M, Harris MH, Li C,
Lindsten T and Thompson CB: Growth factor regulation of autophagy
and cell survival in the absence of apoptosis. Cell. 120:237–248.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Y, Li X, Wu X, He C, Guo L, Zhang S,
Xiao Y, Guo W and Tan B: Autophagy-related proteins LC3 and
Beclin-1 impact the efficacy of chemoradiation on esophageal
squamous cell carcinoma. Pathol Res Pract. 209:562–567. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Youn CK, Kim J, Park JH, Do NY and Cho SI:
Role of autophagy in cisplatin-induced ototoxicity. Int J Pediatr
Otorhinolaryngol. 79:1814–1819. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang Y, Guo C, Vasko MR and Kelley MR:
Implications of apurinic/apyrimidinic endonuclease in reactive
oxygen signaling response after cisplatin treatment of dorsal root
ganglion neurons. Cancer Res. 68:6425–6434. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
DeHaan RD, Yazlovitskaya EM and Persons
DL: Regulation of p53 target gene expression by cisplatin-induced
extracellular signal-regulated kinase. Cancer Chemother Pharmacol.
48:383–388. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu H, Luo H, Zhang W, Shen Z, Hu X and
Zhu X: Molecular mechanisms of cisplatin resistance in cervical
cancer. Drug Des Devel Ther. 10:1885–1895. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kaushal GP, Kaushal V, Herzog C and Yang
C: Autophagy delays apoptosis inrenal tubular epithelial cells in
cisplatin cytotoxicity. Autophagy. 4:710–712. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kubisch J, Turei D, Földvári-Nagy L, Dunai
ZA, Zsákai L, Varga M, Vellai T, Csermely P and Korcsmáros T:
Complex regulation of autophagy in cancer-integrated approaches to
discover the networks that hold a double-edged sword. Semin Cancer
Biol. 23:252–261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tanida I: Autophagosome formation and
molecular mechanism of autophagy. Antioxid Redox Signal.
14:2201–2214. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao R, Chen M, Jiang Z, Zhao F, Xi B,
Zhang X, Fu H and Zhou K: Platycodin-D induced autophagy in
non-small cell lung cancer cells via PI3K/Akt/mTOR and MAPK
Signaling Pathways. J Cancer. 6:623–631. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsai JP, Lee CH, Ying TH, Lin CL, Hsueh JT
and Hsieh YH: Licochalcone A induces autophagy through
PI3K/Akt/mTOR inactivation and autophagy suppression enhances
Licochalcone A-induced apoptosis of human cervical cancer cells.
Oncotarget. 6:28851–28866. 2015.PubMed/NCBI
|
